Trial intelligence / Profile preview

Phase 3 trial of aripiprazole for manic or mixed episodes in bipolar I disorder

jRCT2080220513Phase 3

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in bipolar I disorder comparing Aripiprazole with Placebo (2 arms).

02

Drugs

aripiprazole
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on jRCT2080220513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call